somaxon pharmaceuticals
Analyst Coverage
About Us Product Canidates Therapuetic Areas Insomnia Market Investor Releations News Contact Us
Home > Investor Relations > Analyst Coverage
Analyst Coverage
Firm Analyst
Friedman, Billings, Ramsey & Co   Coverage in Transition
Merriman Curhan Ford   Coverage in Transition
Morgan Stanley   Coverage in Transition
Morningstar   Brian Laegeler
Natixis Bleischroeder   Corey Davis
Piper Jaffray   Coverage in Transition
RBC Capital Markets   Ken Trbovich
Thomas Weisel Partners   Donald B. Ellis, Pharm.D.

Somaxon Pharmaceuticals, Inc. is followed by the analyst(s) listed above. This list may not be all-inclusive. Please note that any opinions, estimates or forecasts regarding Somaxon Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Somaxon Pharmaceuticals, Inc. or its management. Somaxon Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.